SLC6A14P1

Across TCGA pan-cancer cohorts, SLC6A14P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated SLC6A14P1 data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher SLC6A14P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC6A14P1 expression acts as an unfavorable survival marker, although some lineages such as GBM and ESCA show a favorable association.

GBM, LUSC, and KIRC are the cancer types where SLC6A14P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.507	0.187	.006	36	view →
LUSC	DFS	Tertile	II,III,IV	0.152	0.760	<.001	36	view →
KIRC	DFS	Tertile	IV	0.083	0.651	<.001	30	view →
ESCA	DFS	Tertile	III,IV	0.560	0.255	.011	18	view →
BLCA	OS	Tertile	IV	0.082	0.575	.002	18	view →
THYM	DFS	Tertile	All	0.092	0.872	<.001	18	view →
LIHC	DFS	Tertile	All	0.150	0.536	.005	18	view →
UCS	OS	Tertile	III,IV	1.000	0.301	.047	12	view →
MESO	OS	Quartile	All	0.426	0.226	.042	2	view →
STAD	DFS	Median	III,IV	0.385	0.553	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

SLC6A14P1–GBM (OS)

Open the GBM breakdown →